Combined use of coils and Onyx for transcatheter closure of coronary artery fistulae

EuroIntervention. 2018 Apr 6;13(18):e2130-e2137. doi: 10.4244/EIJ-D-17-00632.

Abstract

Aims: The aim of this study was to evaluate the safety and efficacy of combined endovascular coiling and Onyx embolisation in patients with a coronary artery fistula (CAF).

Methods and results: Between September 2014 and September 2016, 26 patients with CAFs were enrolled in our study for attempted combined therapy using coils and Onyx. The mean age of patients was 64.0±9.5 years (range, 44-78 years). CAFs were large in 10 and medium in 16 patients. The mean number of coils used was 3.1±1.2 (range, two to six), and the average volume of Onyx was 0.4±0.1 ml (range, 0.2-0.6 ml). Immediate post-embolisation angiography demonstrated that complete occlusion was achieved in 23 patients (88.5%) and a small residual fistula was achieved in three patients (11.5%). Follow-up imaging (median, 11.5 months; range, nine to 20) revealed stable occlusion of CAF in 21 cases (80.8%), trivial recanalisation in four cases (15.4%), and large recanalisation in only one case (3.8%). Re-closure was performed in the patient with large recanalisation. During the follow-up period, no deaths, severe procedure-related complications, or new symptoms occurred.

Conclusions: In selected patients with CAF, transcatheter embolisation in combined therapy using coils and Onyx appears to be a valid option, providing a high success rate and low rate of recanalisation.

Publication types

  • Video-Audio Media

MeSH terms

  • Adult
  • Aged
  • Arteriovenous Fistula / diagnostic imaging
  • Arteriovenous Fistula / physiopathology
  • Arteriovenous Fistula / therapy*
  • Cardiac Catheterization / adverse effects
  • Cardiac Catheterization / instrumentation*
  • Computed Tomography Angiography
  • Coronary Angiography / methods
  • Coronary Vessel Anomalies / diagnostic imaging
  • Coronary Vessel Anomalies / physiopathology
  • Coronary Vessel Anomalies / therapy*
  • Dimethyl Sulfoxide / administration & dosage*
  • Embolization, Therapeutic / adverse effects
  • Embolization, Therapeutic / instrumentation*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polyvinyls / administration & dosage*
  • Preliminary Data
  • Retrospective Studies
  • Tantalum / administration & dosage*
  • Time Factors
  • Treatment Outcome

Substances

  • Onyx 34
  • Polyvinyls
  • Tantalum
  • Dimethyl Sulfoxide